“TechNavio Announces the Publication of its Report – Global Central Nervous System Drugs Market 2011-2015
TechNavio today launched its report Global Central Nervous System Drugs Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; “The launch of novel molecules is expected to fulfill unmet needs and drive the growth of the Global Central Nervous System (CNS) Drugs market in the coming years. For instance, many orally administered novel molecules are in the pipeline for multiple sclerosis. Also, in the case of Alzheimer’s disease there are products in the pipeline that include novel molecules which target the underlying causes of the disease and thus offer clinical benefits to patients.”
According to the report, the probability of occurrence of mental disorders increases with age and thus the increasing size of the aging population drives the growth of the Global CNS Drugs market.
Further, the report also discusses that one of the most important challenges in the market is the patent expiration of some of the key CNS drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit http://goo.gl/emzId
Follow us on Twitter @ Technavio”
Buy your copy of this report @ http://www.reportsnreports.com/reports/178680-global-central-nervous-system-drugs-market-2011-2015.html
Published: July 2012
No. of Pages: 56
Price: Single User License: US$2000 Corporate User License: US$ 3000
Table Of contents
01. Executive Summary
02. Introduction
03. Market Coverage
Overview
Product Offerings
04. Market Landscape
Global Central Nervous System Drugs Market
Market Size
Key Market Segments
04.1 Global Antipsychotics Market
04.2 Global Antidepressants Market
04.3 Global Antiepileptic Drugs Market
04.4 Global Anti-Alzheimer”s Drugs Market
04.5 Global ADHD Drugs Market
04.6 Global Hypnotics Market
04.7 Global Anti-Parkinson”s Drugs Market
04.8 Global Antimigraine Drugs Market
Segmentation of Global Central Nervous System Drugs Market
Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
USA
Japan
Germany
07. Rate of Incidence and Prevalence
08. Vendor Landscape
Matrix of the Product Portfolio Matrix
Vendor Landscape of the Leading CNS Drugs Market Segments
08.1 Global Antipsychotics Market Segment
08.2 Global Antidepressants Market Segment
08.3 Global Antiepileptic Drugs Market Segment
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Eli Lilly and Co.
Business Overview
SWOT Analysis
15.2 Pfizer Inc.
Business Overview
SWOT Analysis
15.3 AstraZeneca plc
Business Overview
SWOT Analysis
15.4 Johnson and Johnson Ltd.
Business Overview
SWOT Analysis
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Central Nervous System Drugs Market 2011-2015 (US$ billion)
Exhibit 2: Global Central Nervous System Drugs Market Segmentation 2011
Exhibit 3: Global Central Nervous System Drugs Market by Product Segmentation 2011-2015 (percent)
Exhibit 4: Global Antipsychotics Market 2011-2015 (US$ billion)
Exhibit 5: Global Antidepressants Market 2011-2015 (US$ billion)
Exhibit 6: Global Antiepileptic Drugs Market 2011-2015 (US$ billion)
Exhibit 7: Global Anti-Alzheimer”s Drugs Market 2011-2015 (US$ billion)
Exhibit 8: Global Attention Deficit Hyperactivity Disorder Drugs Market 2011-2015 (US$ billion)
Exhibit 9: Global Hypnotics Market 2011-2015 (US$ billion)
Exhibit 10: Global Anti-Parkinson”s Drugs Market 2011-2015 (US$ billion)
Exhibit 11: Global Antimigraine Drugs Market 2011-2015 (US$ billion)
Exhibit 12: Global Central Nervous System Market by Overall Market Segmentation (US$ billion)
Exhibit 13: Global Central Nervous System Drugs Market by Geographical Segmentation 2011
Exhibit 14: Global Central Nervous System Drugs Market by Vendor Segmentation 2011
Exhibit 15: Global Antipsychotics Market by Vendor Segmentation 2011
Exhibit 16: Global Antidepressants Market by Vendor Segmentation 2011
Exhibit 17: Global Antiepileptic Drugs Market by Vendor Segmentation 2011
Contact: sales@reportsandreports.com
